The Therapeutic Aryl Hydrocarbon Receptor-Modulating Agent Tapinarof Regulates SEMA3A Expression in Human Keratinocytes through NRF2

J Invest Dermatol. 2024 Mar;144(3):710-713.e8. doi: 10.1016/j.jid.2023.10.002. Epub 2023 Oct 12.

¹ Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: tsuji.gaku.893@m.kyushu-u.ac.jp.
² Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
³ Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

No abstract available

Keywords: Aryl hydrocarbon receptor; Atopic dermatitis; NRF2; SEMA3A; Tapinarof.

MeSH terms